Cognitive outcomes of prenatal antiepileptic drug exposure

被引:21
|
作者
Inoyama, Katherine [1 ]
Meador, Kimford J. [1 ]
机构
[1] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
关键词
Antiepileptic drugs; Cognitive; Epilepsy; Pregnancy; Teratogen; IN-UTERO EXPOSURE; ANTENATAL MAGNESIUM-SULFATE; NEURONAL MEMBRANE ORDER; SCHOOL-AGE OUTCOMES; PHENYTOIN EXPOSURE; VALPROIC ACID; CELL-DEATH; PSYCHOLOGICAL-DEVELOPMENT; PSYCHOMOTOR DEVELOPMENT; ANTICONVULSANT DRUGS;
D O I
10.1016/j.eplepsyres.2015.04.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antiepileptic drugs (AEDs) have been known to have teratogenic effects foil. a little over 50 years. While early reports focused on fetal malformations, there has been an increasing amount of data over the last few decades exploring the cognitive outcomes of offspring exposed to AEDs in utero. Although the challenges of confounding factors and varied methodologies have led to inconsistent results, the negative impact of some of the agents, such as valproate, have become clear. Further studies are needed to evaluate the cognitive effects of prenatal exposure to many AEDs which have not been tested, to clarify the effects of existing AEDs which have yielded mixed results, and to better understand the effects of polytherapy. Research in animal models is warranted to screen AEDs for their effects on cognition in exposed offspring and to further our understanding of the underlying mechanisms by which AEDs exert their harmful effects on the developing brain. And finally, new AEDs without these harmful effects and agents which can prevent or reverse the negative consequences imparted by AED therapy on cognition should be sought. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 50 条
  • [41] Neurologic birth defects after prenatal exposure to antiepileptic drugs
    Uziel, Daniela
    Rozental, Renato
    EPILEPSIA, 2008, 49 : 35 - 42
  • [42] Prenatal antiepileptic exposure associates with neonatal DNA methylation differences
    Smith, Alicia K.
    Conneely, Karen N.
    Newport, D. Jeffrey
    Kilaru, Varun
    Schroeder, James W.
    Pennell, Page B.
    Knight, Bettina T.
    Cubells, Joseph C.
    Stowe, Zachary N.
    Brennan, Patricia A.
    EPIGENETICS, 2012, 7 (05) : 458 - 463
  • [43] Outcomes of prenatal antidepressant exposure
    Simon, GE
    Cunningham, ML
    Davis, RL
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (12): : 2055 - 2061
  • [44] Infant monkey hyperexcitability after prenatal exposure to antiepileptic compounds
    Phillips, NK
    Lockard, JS
    EPILEPSIA, 1996, 37 (10) : 991 - 999
  • [45] Neurodevelopmental Effects of Fetal Antiepileptic Drug Exposure
    Velez-Ruiz, Naymee J.
    Meador, Kimford J.
    DRUG SAFETY, 2015, 38 (03) : 271 - 278
  • [46] Antiepileptic drugs during pregnancy and cognitive outcomes
    Lindhout, Dick
    LANCET NEUROLOGY, 2013, 12 (03): : 219 - 220
  • [47] Neurodevelopmental Effects of Fetal Antiepileptic Drug Exposure
    Naymee J. Velez-Ruiz
    Kimford J. Meador
    Drug Safety, 2015, 38 : 271 - 278
  • [48] RETROSPECTIVE CASE SERIES OF BIRTH DEFECTS CAN PREDICT MALFORMATION PATTERNS ASSOCIATED WITH PRENATAL ANTIEPILEPTIC DRUG EXPOSURE
    Flipsen-Ten Berg, K.
    van Oppen, C.
    Wentges-van Holthe, N.
    Bulk, S.
    Lindhout, D.
    EPILEPSIA, 2009, 50 : 200 - 200
  • [49] Cognitive Outcomes at Ages 2, 3, and 4.5 Years in Children Exposed In Utero to Antiepileptic Drug
    Meador, Kimford J.
    Baker, Gus A.
    Browning, Nancy
    Clayton-Smith, Jill
    Cohen, Morris
    Crawford, Todd
    Kalayjian, Laura
    Kanner, Andres
    Liporace, Joyce
    Pennell, Page
    Privitera, Michael
    Loring, David
    NEUROLOGY, 2011, 76 (09) : A15 - A15
  • [50] Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure
    Forcelli, Patrick A.
    Janssen, Megan J.
    Stamps, Lauren A.
    Sweeney, Cameron
    Vicini, Stefano
    Gale, Karen
    EPILEPSIA, 2010, 51 : 18 - 23